Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Market price (% of par)
-
103.84%
-
Total 13F principal
-
$396,506,300
-
Principal change
-
-$69,543,000
-
Total reported market value
-
$413,180,185
-
Number of holders
-
44
-
Value change
-
-$70,368,448
-
Number of buys
-
12
-
Number of sells
-
25
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q2 2021
As of 30 Jun 2021,
BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 was held by
44 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$396,506,300
in principal (par value) of the bond.
The largest 10 bondholders included
MACKAY SHIELDS LLC, ADVENT CAPITAL MANAGEMENT /DE/, PFM Health Sciences, LP, SHENKMAN CAPITAL MANAGEMENT INC, ROYAL BANK OF CANADA, Opti Capital Management, LP, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BAKER BROS. ADVISORS LP, and Man Group plc.
This page lists
44
institutional bondholders reporting positions
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.